PMC:7600245 / 56294-56488 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T246","span":{"begin":125,"end":133},"obj":"Disease"}],"attributes":[{"id":"A246","pred":"mondo_id","subj":"T246","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Given the above activities, a high dose of leflunomide is being evaluated for the treatment of ambulatory patients with mild COVID-19 at the University of Chicago Medicine (NCT04361214; n = 20)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T570","span":{"begin":16,"end":26},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T571","span":{"begin":28,"end":29},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Given the above activities, a high dose of leflunomide is being evaluated for the treatment of ambulatory patients with mild COVID-19 at the University of Chicago Medicine (NCT04361214; n = 20)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T56250","span":{"begin":43,"end":54},"obj":"Chemical"}],"attributes":[{"id":"A89441","pred":"chebi_id","subj":"T56250","obj":"http://purl.obolibrary.org/obo/CHEBI_6402"}],"text":"Given the above activities, a high dose of leflunomide is being evaluated for the treatment of ambulatory patients with mild COVID-19 at the University of Chicago Medicine (NCT04361214; n = 20)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T422","span":{"begin":0,"end":194},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Given the above activities, a high dose of leflunomide is being evaluated for the treatment of ambulatory patients with mild COVID-19 at the University of Chicago Medicine (NCT04361214; n = 20)."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1725","span":{"begin":106,"end":114},"obj":"Species"},{"id":"1734","span":{"begin":43,"end":54},"obj":"Chemical"},{"id":"1737","span":{"begin":125,"end":133},"obj":"Disease"}],"attributes":[{"id":"A1725","pred":"tao:has_database_id","subj":"1725","obj":"Tax:9606"},{"id":"A1734","pred":"tao:has_database_id","subj":"1734","obj":"MESH:D000077339"},{"id":"A1737","pred":"tao:has_database_id","subj":"1737","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Given the above activities, a high dose of leflunomide is being evaluated for the treatment of ambulatory patients with mild COVID-19 at the University of Chicago Medicine (NCT04361214; n = 20)."}